Executive Order 14256: Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China as Applied to Low-Value Imports

What the order contains

Section headings exactly as they appear in the official text.

• Sec. 1. Purpose
• Sec. 2. Assessment of Duties on Low-Value Products of the PRC
• Sec. 3. Implementation of Duty
• Sec. 4. Homeland Security Authorities
• Sec. 5. Monitoring
• Sec. 6. General Provisions

Section 1, quoted from the order

Verbatim text from the signed document. These are the words of the document, not SaveYourState’s.

Many shippers based in the People's Republic of China (PRC) hide illicit substances and conceal the true contents of shipments sent to the United States through deceptive shipping practices. These shippers often avoid detection due to administration of the de minimis exemption under section 321(a)(2)(C) of the Tariff Act of 1930, as amended (19 U.S.C. 1321(a)(2)(C)). As noted in Executive Order 14195 of February 1, 2025 (Imposing Duties to Address the Synthetic Opioid Supply Chain in the People's Republic of China), as amended by Executive Order 14228 of March 3, 2025 (Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China), these exports play a significant role in the synthetic opioid crisis in the United States. […]

Federal Register notes

See: EO 14195, February 1, 2025; EO 14200, February 5, 2025; EO 14228, March 3, 2025; EO 14257, April 2, 2025; EO 14259, April 8, 2025 Superseded by: EO 14324, July 30, 2025 (in part)